中国口腔产业(08406) - 2025 - 年度业绩
CHINA ORAL INDCHINA ORAL IND(HK:08406)2026-03-31 13:40

Financial Performance - For the fiscal year ending December 31, 2025, the company reported total revenue of RMB 167,645,000, a decrease of 27.5% from RMB 230,959,000 in 2024[4] - The gross profit for the same period was RMB 14,129,000, down 62.1% from RMB 37,251,000 in 2024[4] - The company incurred a loss before tax of RMB 43,490,000, compared to a loss of RMB 16,439,000 in the previous year, representing a significant increase in losses[4] - The net loss for the year was RMB 42,717,000, compared to RMB 16,439,000 in 2024, indicating a worsening financial position[4] - The company's cash and bank balances fell to RMB 39,936,000 in 2025 from RMB 57,045,000 in 2024, a decrease of 30.0%[5] - The company reported a basic and diluted loss per share of RMB 3.2 for 2025, compared to RMB 1.5 in 2024, indicating a worsening performance on a per-share basis[4] - The group reported an annual loss of approximately RMB 42,717,000, an increase of about RMB 26,278,000 or 159.9% compared to the previous year[50] Revenue Breakdown - Revenue from the sale of inflatable products and related accessories decreased to RMB 96,439,000 in 2025 from RMB 170,790,000 in 2024, representing a decline of approximately 43.4%[15] - Revenue from dental clinic services and other services rose to RMB 14,713,000 in 2025 from RMB 10,257,000 in 2024, an increase of about 43.3%[15] - Revenue from the inflatable products business in 2025 was approximately RMB 104,588,000, down RMB 70,122,000 or 40.1% from RMB 174,710,000 in 2024[41] - The dental clinic business generated revenue of approximately RMB 24,271,000 in 2025, an increase of RMB 1,740,000 or 7.7% compared to RMB 22,531,000 in 2024[41] - The yarn and polyester business accounted for approximately 23.1% of total revenue in 2025, with revenue of RMB 38,786,000, up RMB 5,068,000 or 15.0% from RMB 33,718,000 in 2024[41] Assets and Liabilities - Total assets decreased to RMB 166,235,000 in 2025 from RMB 202,459,000 in 2024, reflecting a decline of 17.9%[5] - Current liabilities also decreased to RMB 55,523,000 in 2025 from RMB 91,763,000 in 2024, a reduction of 39.5%[5] - The net asset value decreased to RMB 96,708,000 in 2025 from RMB 107,138,000 in 2024, a reduction of about 9.9%[6] - The company's total equity attributable to owners decreased from RMB 107,138,000 in 2024 to RMB 96,708,000 in 2025[6] - Lease liabilities increased significantly to RMB 12,800,000 in 2025 from RMB 1,387,000 in 2024[6] Expenses and Costs - Distribution and selling expenses totaled approximately RMB 11,804,000 in 2025, a decrease of RMB 14,492,000 or 55.1% from RMB 26,296,000 in 2024[45] - Administrative expenses increased to approximately RMB 27,061,000 in 2025, up RMB 6,668,000 or 32.7% from RMB 20,393,000 in 2024[46] - The financing cost for the group in 2025 was approximately RMB 423,000, a decrease of about RMB 330,000 or 43.8% from RMB 753,000 in 2024[49] Share Capital and Options - The company’s issued share capital increased to RMB 50,000,000 as of December 31, 2025, reflecting the issuance of shares for the acquisition of subsidiaries[32] - The company completed a share subscription on January 24, 2025, issuing 228,000,000 ordinary shares at HKD 0.14 per share, resulting in net proceeds of approximately HKD 31,720,000[63] - The net proceeds from the share subscription are allocated as follows: HKD 20,000,000 for potential acquisitions or investment opportunities and HKD 11,720,000 for general working capital[64] - The company granted 80,000,000 share options under the 2017 Share Option Scheme, which remain unexercised as of December 31, 2025[70] - The company plans to terminate the 2017 Share Option Scheme and adopt a new scheme in 2025, pending shareholder approval[69] Employee and Operational Metrics - As of December 31, 2025, the group had 524 full-time employees, a decrease from 608 in 2024[62] - Total employee compensation, including director remuneration, was approximately RMB 51,214,000 in 2025, slightly up from RMB 51,161,000 in 2024[62] Other Financial Information - The company recorded a significant foreign exchange loss of RMB 1,467,000 in 2025, contrasting with a foreign exchange gain of RMB 1,563,000 in 2024[27] - Other income, including interest income from bank deposits, totaled RMB 5,220,000 in 2025, compared to RMB 2,586,000 in 2024[27] - The group recognized impairment losses related to property, plant, and equipment, and other intangible assets totaling approximately RMB 15,399,000[48] - The group did not recommend any dividend payments for 2025, consistent with 2024[51]

CHINA ORAL IND-中国口腔产业(08406) - 2025 - 年度业绩 - Reportify